Mazindol in the treatment of narcolepsy
Authors:
- 29 January 2009
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 60 (4) , 250-254
Abstract
Thirty-four subjects with the narcoleptic syndrome were treated with mazindol 3--8 mg daily for 1 year. Treatment cuased a sustained improvement in narcolepsy, but had no effect on cataplexy or sleep paralysis. The response to mazindol was excellent in six subjects, good in 14, moderate in 12 and poor in two. No cardiovascular effects, haematological toxicity, tolerance or dependence occurred. Mazindol 6 mg had the same effect on narcolepsy as d-amphetamine 50 mg, but caused less side effects.Keywords
This publication has 4 references indexed in Scilit:
- The Treatment of Narcolepsy-Cataplexy with Nocturnal Gamma-HydroxybutyrateCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 1979
- Anorectic DrugsDrugs, 1976
- NATURAL HISTORY, SYMPTOMS AND TREATMENT OF THE NARCOLEPTIC SYNDROMEActa Neurologica Scandinavica, 1975
- Subjective Effects of Two Anorexigenic Agents Fenfluramine and AN 448 in Amphetamine‐Dependent SubjectsBritish Journal of Addiction to Alcohol & Other Drugs, 1972